Key Strategic Developments and Emerging Changes Shaping the Cloud-Connected Automated Intravenous (IV) Compounding Market Landscape

The cloud-connected automated intravenous (IV) compounding market is poised for remarkable expansion in the coming years, driven by technological advancements and evolving healthcare needs. As integration of cloud-based systems and AI becomes more prevalent, this market is expected to transform how IV medications are prepared and managed, enhancing safety and efficiency across healthcare settings.

Projected Market Expansion of the Cloud-Connected Automated Intravenous (IV) Compounding Market
The market for cloud-connected automated IV compounding is forecasted to grow rapidly, reaching a value of $5.03 billion by 2030. This reflects a strong compound annual growth rate (CAGR) of 16.5%. The anticipated rise is fueled by the increasing adoption of cloud-based monitoring solutions and the development of AI-driven error detection technologies. Additionally, heightened investments in compact, modular robotic systems, expansion into homecare and decentralized pharmacy applications, and a growing emphasis on interoperability alongside advanced data analytics platforms are significant contributors to this market's growth. Key trends shaping the future of this sector include advancements in cloud-connected workflow management, innovative AI and machine learning techniques for predictive compounding, the creation of smart consumables and sensor technologies, focused research on oncology-specific automation, and growing support for scalable, remote monitoring deployment models.

Download a free sample of the cloud-connected automated intravenous (iv) compounding market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30558&type=smp

Leading Corporations Driving Innovation in the Cloud-Connected Automated Intravenous (IV) Compounding Market
Several prominent players are currently shaping the cloud-connected automated IV compounding landscape. These include McKesson Corporation, Becton dic*kinson and Company, Baxter International Inc., B. Braun Melsungen SE, Fresenius Kabi AG, Grifols S.A., ICU Medical Inc., Syntegon Technology GmbH, Omnicell Inc., Marchesini Group S.p.A., Swisslog Healthcare, ScriptPro LLC, Parata Systems LLC, ARxIUM Inc., Equashield LLC, Health Robotics S.r.l., Rommelag AG, NewIcon Oy, DoseEdge, and Aesynt Inc. A notable development occurred in October 2026 when Omnicell Inc., a US-based leader in healthcare automation and medication management, acquired ANiGENT LLC. This strategic move aims to enhance Omnicell's cloud-enabled medication management platform by incorporating sophisticated drug diversion detection and intelligence features, which will strengthen their offerings in connected automation, especially in cloud-connected IV compounding workflows. ANiGENT LLC specializes in cloud-connected automated IV compounding solutions and is also based in the United States.

Emerging Trends Elevating the Cloud-Connected Automated Intravenous (IV) Compounding Industry
Market leaders are focusing on improving automated systems by incorporating cloud-enabled monitoring and compliance tracking to boost accuracy in sterile preparation, reduce medication mistakes, and ensure adherence to regulatory standards. Cloud-enabled monitoring and compliance tracking systems integrate software and hardware tools that provide healthcare facilities with real-time visibility into IV compounding processes, maintain electronic audit trails, and support sterility and quality standards management across various locations. For instance, in May 2025, the United States Food and Drug Administration (FDA) issued updated guidance and enforcement initiatives under section 503B of the Federal Food, Drug, and Cosmetic Act. These regulations require outsourcing facilities to implement stringent quality control and documentation practices for compounded sterile products. The FDA's recommendations encourage the adoption of automated IV compounding technologies equipped with cloud-based monitoring, electronic record-keeping, and remote quality oversight capabilities to meet these requirements.

View the full cloud-connected automated intravenous (iv) compounding market report:
https://www.thebusinessresearchcompany.com/report/cloud-connected-automated-intravenous-iv-compounding-market-report

Detailed Segmentation of the Cloud-Connected Automated Intravenous (IV) Compounding Market
This market report segments the cloud-connected automated IV compounding industry by several key categories:
1) Component Type: Software and Services
2) Deployment Model: Cloud and On-Premises
3) Organization Size: Large Enterprises and Small and Medium Enterprises
4) Application Areas: Lead Generation, Sales Forecasting, Customer Engagement, Sales Analytics, and Other Applications
5) End-User Industries: Banking, Financial Services, and Insurance (BFSI), Retail and E-commerce, Healthcare, IT and Telecom, Manufacturing, and Other Sectors

Additional subcategories include:
- Software types such as Customer Relationship Management Integration, Sales Automation Platforms, Conversational Intelligence Tools, Workflow Optimization Software, and Sales Enablement Solutions
- Services encompassing Implementation, Training and Support, Consulting, System Integration, and Managed Services

This granular segmentation provides a comprehensive view of the market, highlighting diverse applications and user groups, and supporting strategic decisions based on deployment preferences and organizational needs.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.